Şükrü Beydemir
- Molecular Biology top 1%
- Pharmacology top 0.1%
- Organic Chemistry top 0.5%
- Clinical Biochemistry top 0.2%
- Cell Biology top 1%
- Co-authors
- Yeliz Demirİlhami GülçınCüneyt TürkeşÖmer İrfan KüfrevioğluDeniz EkinciMesut IşıkParham TaslımıHakan Söyüt
- Topics
- Enzyme function and inhibition (108 papers)Cholinesterase and Neurodegenerative Diseases (75 papers)Paraoxonase enzyme and polymorphisms (34 papers)
- Journals
- SHILAP Revista de lepidopterologíaChemosphereArchives of Biochemistry and Biophysics
- Partner nations
- TürkiyeSaudi ArabiaItaly
In The Last Decade
Şükrü Beydemir
213 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Biology 5.4k
- Pharmacology 3.3k
- Organic Chemistry 3.3k
- Clinical Biochemistry 969
- Cell Biology 897
Countries citing papers authored by Şükrü Beydemir
This map shows the geographic impact of Şükrü Beydemir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükrü Beydemir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükrü Beydemir more than expected).
Fields of papers citing papers by Şükrü Beydemir
This network shows the impact of papers produced by Şükrü Beydemir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükrü Beydemir. The network helps show where Şükrü Beydemir may publish in the future.
Co-authorship network of co-authors of Şükrü Beydemir
This figure shows the co-authorship network connecting the top 25 collaborators of Şükrü Beydemir. A scholar is included among the top collaborators of Şükrü Beydemir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükrü Beydemir. Şükrü Beydemir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 18 | |
| 3 | 5 | |
| 4 | Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studiesbreakdown → | 61 |
| 5 | 19 | |
| 6 | 61 | |
| 7 | 6 | |
| 8 | 19 | |
| 9 | 18 | |
| 10 | 2 | |
| 11 | 16 | |
| 12 | 7 | |
| 13 | 64 | |
| 14 | 93 | |
| 15 | 58 | |
| 16 | 86 | |
| 17 | 63 | |
| 18 | Koyun Karaciğerinden Alkol Dehidrogenaz: Saflaştırma, Karakterizasyon, ve Bazı Antibiyotiklerin Etkileri | 1 |
| 19 | 50 | |
| 20 | 35 |
About Şükrü Beydemir
Şükrü Beydemir is a scholar working on Clinical Biochemistry, Pharmacology and Biochemistry, having authored 222 papers that have together received 9.5k indexed citations. Recurring topics across this work include Enzyme function and inhibition (108 papers), Cholinesterase and Neurodegenerative Diseases (75 papers) and Paraoxonase enzyme and polymorphisms (34 papers). The work is most often cited by research in Pharmacology (3.3k citations), Clinical Biochemistry (969 citations) and Organic Chemistry (3.3k citations). Şükrü Beydemir has collaborated with scholars based in Türkiye, Saudi Arabia and Italy. Frequent co-authors include Yeliz Demir, İlhami Gülçın, Cüneyt Türkeş, Ömer İrfan Küfrevioğlu, Deniz Ekinci, Mesut Işık, Parham Taslımı, Hakan Söyüt, Mustafa Arslan and Zübeyir Huyut. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemosphere and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.